Modafinil (Provigil)
Wakefulness-promoting agent with a distinct mechanism from traditional stimulants. Reaches steady state in 2-4 days. R-enantiomer (armodafinil) has a longer half-life (10-17h) than S-enantiomer (3-5h).
Projected serum levels — 200 mg, once daily
Maintenance schedule: 200 mg once daily (oral).
Loading schedule: 299 mg on day 1, then 200 mg once daily — reaching therapeutic levels sooner.
Modeled steady state after ~2 days: peak ≈ 262 mg, trough ≈ 101 mg body load. Population-based estimate over 15 days for a 200 mg dose at a 70 kg reference body mass — the interactive app scales curves to your doses, timing, and body mass.
Key facts
- Category
- Eugeroic
- Route modeled
- Oral
- Model confidence
- inferred
- Half-life
- 15 h
- Common dose
- 200 mg
- Suggested maximum
- 400 mg/day
- Reference dose range
- 50–400 mg (single dose)
- Suggested cadence
- once daily
- Validated against
- 200 mg oral — Cmax 4.5 mg/L at 3 h
Documented interactions
-
danger
Alfuzosin (Uroxatral) + Modafinil (Provigil)
Modafinil (Provigil) inducer of CYP3A4 predicted to change Alfuzosin (Uroxatral) AUC by ~0.50x
-
danger
Alprazolam (Xanax) + Modafinil (Provigil)
Modafinil (Provigil) inducer of CYP3A4 predicted to change Alprazolam (Xanax) AUC by ~0.50x
-
danger
Amlodipine (Norvasc) + Modafinil (Provigil)
Modafinil (Provigil) inducer of CYP3A4 predicted to change Amlodipine (Norvasc) AUC by ~0.50x
-
danger
Astaxanthin + Modafinil (Provigil)
Modafinil (Provigil) inducer of CYP3A4 predicted to change Astaxanthin AUC by ~0.50x
-
danger
Atogepant (Qulipta) + Modafinil (Provigil)
Modafinil (Provigil) inducer of CYP3A4 predicted to change Atogepant (Qulipta) AUC by ~0.50x
-
danger
Azithromycin (Z-Pack / Zithromax) + Modafinil (Provigil)
Modafinil (Provigil) inducer of CYP3A4 predicted to change Azithromycin (Z-Pack / Zithromax) AUC by ~0.50x
Serum checks 304 modeled interaction pairings for modafinil (provigil) across your whole stack — absorption conflicts, enzyme inhibition, and nutrient depletion included.
Research behind this entry
-
Modafinil for excessive sleepiness associated with shift-work sleep disorder
RCT of 209 patients found modafinil 200 mg significantly reduced excessive sleepiness, improved sustained attention, and reduced driving accidents in shift workers.
-
Effects of modafinil on cognitive and meta-cognitive performance
Systematic review of 24 studies found modafinil consistently enhanced executive function, attention, and learning in non-sleep-deprived healthy individuals, with minimal side effects.
-
Modafinil Treatment of Cocaine Dependence: A Systematic Review and Meta-Analysis
Meta-analysis of 11 placebo-controlled trials (896 participants) found no overall improvement in cocaine-treatment retention or abstinence. A US-study subgroup showed an abstinence signal, while discontinuations and…
-
Cognitive enhancement effects of stimulants: a randomized controlled trial testing methylphenidate, modafinil, and caffeine.
This citation reports a human clinical study involving a formulation related to Modafinil (Provigil), not the isolated identity. The randomized study compared modafinil with other stimulants; effects remain attributable…
4 published studies referenced in the app, each with a plain-language summary.